SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-767849
Filing Date
2016-11-14
Accepted
2016-11-14 16:46:48
Documents
4
Period of Report
2016-11-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d287475d8k.htm 8-K 15709
2 EX-99.1 d287475dex991.htm EX-99.1 9897
3 GRAPHIC g287475g06z84.jpg GRAPHIC 2758
4 GRAPHIC g287475g32v89.jpg GRAPHIC 3499
  Complete submission text file 0001193125-16-767849.txt   35574
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 161995589
SIC: 2834 Pharmaceutical Preparations